Drugs Approved for Acute Lymphoblastic Leukemia (ALL)：
Abitrexate (Methotrexate)
Arranon (Nelarabine)
Asparaginase Erwinia chrysanthemi
Blinatumomab
Blincyto (Blinatumomab)
Cerubidine (Daunorubicin Hydrochloride)
Clafen (Cyclophosphamide)
Clofarabine
Clofarex (Clofarabine)
Clolar (Clofarabine)
Cyclophosphamide
Cytarabine
Cytosar-U (Cytarabine)
Cytoxan (Cyclophosphamide)
Dasatinib
Daunorubicin Hydrochloride
Doxorubicin Hydrochloride
Erwinaze (Asparaginase Erwinia Chrysanthemi)
Folex (Methotrexate)
Folex PFS (Methotrexate)
Gleevec (Imatinib Mesylate)
Iclusig (Ponatinib Hydrochloride)
Imatinib Mesylate
Marqibo (Vincristine Sulfate Liposome)
Mercaptopurine
Methotrexate
Methotrexate LPF (Methorexate)
Mexate (Methotrexate)
Mexate-AQ (Methotrexate)
Nelarabine
Neosar (Cyclophosphamide)
Oncaspar (Pegaspargase)
Pegaspargase
Ponatinib Hydrochloride
Prednisone
Purinethol (Mercaptopurine)
Purixan (Mercaptopurine)
Rubidomycin (Daunorubicin Hydrochloride)
Sprycel (Dasatinib)
Tarabine PFS (Cytarabine)
Vincasar PFS (Vincristine Sulfate)
Vincristine Sulfate
Vincristine Sulfate Liposome
Drug Combinations Used in Acute Lymphoblastic Leukemia (ALL)：
Hyper-CVAD
Drugs Approved for Acute Myeloid Leukemia (AML)：
Arsenic Trioxide
Cerubidine (Daunorubicin Hydrochloride)
Clafen (Cyclophosphamide)
Cyclophosphamide
Cytarabine
Cytosar-U (Cytarabine)
Cytoxan (Cyclophosphamide)
Daunorubicin Hydrochloride
Doxorubicin Hydrochloride
Idamycin (Idarubicin Hydrochloride)
Idarubicin Hydrochloride
Mitoxantrone Hydrochloride
Neosar (Cyclophosphamide)
Rubidomycin (Daunorubicin Hydrochloride)
Tabloid (Thioguanine)
Tarabine PFS (Cytarabine)
Thioguanine
Trisenox (Arsenic Trioxide)
Vincasar PFS (Vincristine Sulfate)
Vincristine Sulfate
Drug Combinations Used in Acute Myeloid Leukemia (AML)：
ADE
Drugs Approved for Chronic Lymphocytic Leukemia (CLL)
Alemtuzumab
Ambochlorin (Chlorambucil)
Amboclorin (Chlorambucil)
Arzerra (Ofatumumab)
Bendamustine Hydrochloride
Campath (Alemtuzumab)
Chlorambucil
Clafen (Cyclophosphamide)
Cyclophosphamide
Cytoxan (Cyclophosphamide)
Fludara (Fludarabine Phosphate)
Fludarabine Phosphate
Gazyva (Obinutuzumab)
Ibrutinib
Idelalisib
Imbruvica (Ibrutinib)
Leukeran (Chlorambucil)
Linfolizin (Chlorambucil)
Mechlorethamine Hydrochloride
Mustargen (Mechlorethamine Hydrochloride)
Neosar (Cyclophosphamide)
Obinutuzumab
Ofatumumab
Prednisone
Rituxan (Rituximab)
Rituximab
Treanda (Bendamustine Hydrochloride)
Venclexta (Venetoclax)
Venetoclax
Zydelig (Idelalisib)
Drug Combinations Used in Chronic Lymphocytic Leukemia (CLL)：
CHLORAMBUCIL-PREDNISONE
CVP
Drugs Approved for Chronic Myelogenous Leukemia (CML)：
Bosulif (Bosutinib)
Bosutinib
Busulfan
Busulfex (Busulfan)
Clafen (Cyclophosphamide)
Cyclophosphamide
Cytarabine
Cytosar-U (Cytarabine)
Cytoxan (Cyclophosphamide)
Dasatinib
Gleevec (Imatinib Mesylate)
Hydrea (Hydroxyurea)
Hydroxyurea
Iclusig (Ponatinib Hydrochloride)
Imatinib Mesylate
Mechlorethamine Hydrochloride
Mustargen (Mechlorethamine Hydrochloride)
Myleran (Busulfan)
Neosar (Cyclophosphamide)
Nilotinib
Omacetaxine Mepesuccinate
Ponatinib Hydrochloride
Sprycel (Dasatinib)
Synribo (Omacetaxine Mepesuccinate)
Tarabine PFS (Cytarabine)
Tasigna (Nilotinib)
Drugs Approved for Hairy Cell Leukemia：
Intron A (Recombinant Interferon Alfa-2b)
Recombinant Interferon Alfa-2b
Drugs Approved for Meningeal Leukemia：
Cytarabine
Cytosar-U (Cytarabine)
Tarabine PFS (Cytarabine)